文献速递疝与腹壁外科围术期管理与 ERAS

生物补片与合成补片在腹腔镜腹股沟疝修补术中的比较:BIOLAP随机临床试验

Biological vs Synthetic Mesh in Laparoendoscopic Inguinal Hernia Repair: The BIOLAP Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2025-01-01

BIOLAP多中心随机自对照试验纳入491例原发性双侧腹股沟疝成人患者,行腹腔镜修补,一侧随机用生物补片、对侧用合成补片。结论不支持腹腔镜腹股沟疝修补常规使用生物补片。

要点

  • 生物补片未降低6个月术后疼痛,静息VAS两组均为0.3。
  • 生物补片2年复发率11.2%,显著高于合成补片2.5%。
  • 生物补片血清肿发生率33.4%,显著高于合成补片21.6%。

核心结论

  • 生物补片未减少术后疼痛,但2年复发率和血清肿率显著高于合成补片,不支持腹腔镜腹股沟疝修补常规使用生物补片。

研究设计与样本

  • BIOLAP为多中心、随机、自对照临床试验,2017年8月至2021年2月在21家德国认证疝中心开展。
  • 共491例原发性双侧腹股沟疝成人患者,行标准化腹腔镜修补(TAPP或TEP),一侧随机用生物补片、对侧用合成补片,患者与评估者设盲。

临床怎么用

  • 腹腔镜腹股沟疝修补应优先选择合成补片,生物补片不常规用于降低术后疼痛。
  • 使用生物补片需告知患者复发和血清肿风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Chronic postoperative pain and recurrence are relevant complications after inguinal hernia repair. Biological meshes have been proposed as a resorbable alternative to synthetic implants that may reduce postoperative pain. OBJECTIVE: To compare postoperative pain and recurrence rates between biological and synthetic meshes in laparoendoscopic inguinal hernia repair using a self-controlled design. DESIGN, SETTING, AND PARTICIPANTS: The Biological vs Synthetic Mesh in Laparoendoscopic Inguinal Hernia Repair (BIOLAP) trial was a multicenter, randomized, self-controlled clinical trial conducted between August 2017 and February 2021 across 21 certified German hernia centers. A total of 491 adult patients with primary bilateral inguinal hernias underwent laparoendoscopic repair using 1 biological mesh and 1 synthetic mesh. Data analysis was performed from July 2023 to June 2024. INTERVENTION: Patients were randomized to receive a biological or synthetic mesh on the right side; the contralateral side received the alternate material. All patients underwent standardized laparoendoscopic repair (transabdominal preperitoneal plasty or total extraperitoneal plasty), and both patients and assessors were blinded to mesh assignment. MAIN OUTCOMES AND MEASURES: The coprimary outcomes were pain intensity at 6 months (measured using the visual analog scale) and hernia recurrence at 2 years. Secondary outcomes included seroma, hematoma, surgical site infection, and patient satisfaction. RESULTS: Among 491 patients (mean [SD] age, 58.5 [14.1] years; 457 [93.1%] male), there was no significant difference in pain at 6 months between biological and synthetic meshes (mean [SD] visual analog scale score at rest, 0.3 [0.9] for both; P = .76). However, the 2-year recurrence rate was significantly higher for biological meshes (53 recurrences [11.2%]) compared with synthetic meshes (12 recurrences [2.5%]) (P < .001). Seroma rates were also significantly higher with biological meshes than with synthetic meshes (164 patients [33.4%] vs 106 patients [21.6%], respectively; P < .001). CONCLUSIONS AND RELEVANCE: Biological meshes did not reduce postoperative pain but were associated with significantly higher recurrence and seroma rates compared with synthetic meshes. These findings do not support the routine use of biological meshes in laparoendoscopic inguinal hernia repair. TRIAL REGISTRATION: German Clinical Trials Register Identifier: DRKS00010178.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Seefeldt CS, Knievel J, Deeb M, et al. Biological vs Synthetic Mesh in Laparoendoscopic Inguinal Hernia Repair: The BIOLAP Randomized Clinical Trial. JAMA Surg. 2025. PMID: 41060645. doi:10.1001/jamasurg.2025.4071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。